Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis

Authored by Nadia N Abuelezam, Alethea W McCormick, Thomas Fussell, Abena N Afriyie, Robin Wood, Victor DeGruttola, Kenneth A Freedberg, Marc Lipsitch, III George R Seage

Date Published: 2016

DOI: 10.1093/aje/kwv344

Sponsors: United States National Institutes of Health (NIH)

Platforms: C++

Model Documentation: Other Narrative

Model Code URLs: Model code not found

Abstract

Little is known about how combining efficacious interventions for human immunodeficiency virus (HIV) prevention could lead to HIV elimination. We used an agent-based simulation model, the HIV calibrated dynamic model, to assess the potential for HIV elimination in South Africa. We examined several scenarios (from continuation of the current status quo to perfect achievement of targets) with differing combinations of male condom use, adult male circumcision, HIV testing, and early antiretroviral therapy (ART). We varied numerous parameters, including the proportion of adult males circumcised, the frequency of condom use during sex acts, acceptance of HIV testing, linkage to health care, criteria for ART initiation, ART viral suppression rates, and loss to follow-up. Maintaining current levels of combination prevention would lead to increasing HIV incidence and prevalence in South Africa, while the perfect combination scenario was projected to eliminate HIV on a 50-year time scale from 2013 to 2063. Perfecting testing and treatment, without changing condom use or circumcision rates, resulted in an 89\% reduction in HIV incidence but not elimination. Universal adult male circumcision alone resulted in a 21\% incidence reduction within 20 years. Substantial decreases in HIV incidence are possible from sufficient uptake of both primary prevention and ART, but with continuation of the status quo, HIV elimination in South Africa is unlikely within a 50-year time scale.
Tags
Infection cost-effectiveness Sub-saharan africa Randomized controlled-trial Antiretroviral therapy Male circumcision Causal inference Preexposure prophylaxis Clinical impact Cote-divoire